The Use of Predimenol After Simple Pain Intervention in High-Risk Patients: A Case Series
MEDICINUS · 2025
DOI: 10.56951/4fb0jj22 ↗Kurz gefasst
Fachartikel in der Zeitschrift MEDICINUS, 2025. Verfasst von Rizaldy Taslim Pinzon und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Effective pain management is a common challenge in clinical practice, whether it involves prescription medications or over-the-counter (OTC) nonsteroidal anti-inflammatory drugs (NSAIDs). The use of NSAIDs has been linked to various risks, including cardiovascular (CV), kidney, and gastrointestinal (GI) complications. Certain group of patients face a higher likelihood of these risks. NSAIDs consumptions have been shown to cause a modest, but steady increase in the chance of experiencing CV events and developing kidney problems. In this case series, we reported a series of inflammatory pain cases. Following simple pain intervention, we administered paracetamol and Predimenol over a 10 day period. The use of Predimenol was proven to be effective in alleviating pain without causing any notable adverse effects.
Zitieren
APA
Pinzon, R. T., & Nugroho, A. A. M. (2025). The Use of Predimenol After Simple Pain Intervention in High-Risk Patients: A Case Series. MEDICINUS. https://doi.org/10.56951/4fb0jj22
Vancouver
Pinzon RT, Nugroho AAM. The Use of Predimenol After Simple Pain Intervention in High-Risk Patients: A Case Series. MEDICINUS. 2025. doi:10.56951/4fb0jj22
BibTeX
@article{Pinzon2025,
author = {Pinzon, Rizaldy Taslim and Nugroho, Aditya Aristo Marvel},
title = {The Use of Predimenol After Simple Pain Intervention in High-Risk Patients: A Case Series},
journal = {MEDICINUS},
year = {2025},
doi = {10.56951/4fb0jj22}
}
EUVIMED